Your browser doesn't support javascript.
loading
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.
Gorini, Giacomo; Fourati, Slim; Vaccari, Monica; Rahman, Mohammad Arif; Gordon, Shari N; Brown, Dallas R; Law, Lynn; Chang, Jean; Green, Richard; Barrenäs, Fredrik; Liyanage, Namal P M; Doster, Melvin N; Schifanella, Luca; Bissa, Massimiliano; Silva de Castro, Isabela; Washington-Parks, Robyn; Galli, Veronica; Fuller, Deborah H; Santra, Sampa; Agy, Michael; Pal, Ranajit; Palermo, Robert E; Tomaras, Georgia D; Shen, Xiaoying; LaBranche, Celia C; Montefiori, David C; Venzon, David J; Trinh, Hung V; Rao, Mangala; Gale, Michael; Sekaly, Rafick P; Franchini, Genoveffa.
Affiliation
  • Gorini G; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Fourati S; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
  • Vaccari M; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Rahman MA; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Gordon SN; Department of Infectious Diseases, GlaxoSmithKline R&D, Research Triangle Park, North Carolina, United States of America.
  • Brown DR; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Law L; Department of Immunology, Center for Innate Immunity and Immune Disease, and Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Chang J; Department of Immunology, Center for Innate Immunity and Immune Disease, and Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Green R; Department of Immunology, Center for Innate Immunity and Immune Disease, and Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Barrenäs F; Department of Immunology, Center for Innate Immunity and Immune Disease, and Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Liyanage NPM; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Doster MN; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Schifanella L; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Bissa M; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Silva de Castro I; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Washington-Parks R; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Galli V; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Fuller DH; Department of Immunology, Center for Innate Immunity and Immune Disease, and Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Santra S; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Agy M; Division of Surgical Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Pal R; Advanced Bioscience Laboratories, Rockville, Maryland, United States of America.
  • Palermo RE; Department of Immunology, Center for Innate Immunity and Immune Disease, and Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Tomaras GD; Division of Surgical Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Shen X; Division of Surgical Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • LaBranche CC; Division of Surgical Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Montefiori DC; Division of Surgical Sciences, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Venzon DJ; Biostatistics and Data Management Section, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Trinh HV; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Gale M; Department of Immunology, Center for Innate Immunity and Immune Disease, and Washington National Primate Research Center, University of Washington, Seattle, Washington, United States of America.
  • Sekaly RP; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
  • Franchini G; Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, Maryland, United States of America.
PLoS Pathog ; 16(3): e1008377, 2020 03.
Article in En | MEDLINE | ID: mdl-32163525

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vagina / Viral Vaccines / Killer Cells, Natural / Monocytes / Simian Immunodeficiency Virus / Vaccination / Th1 Cells / SAIDS Vaccines Type of study: Etiology_studies / Risk_factors_studies Limits: Animals Language: En Journal: PLoS Pathog Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vagina / Viral Vaccines / Killer Cells, Natural / Monocytes / Simian Immunodeficiency Virus / Vaccination / Th1 Cells / SAIDS Vaccines Type of study: Etiology_studies / Risk_factors_studies Limits: Animals Language: En Journal: PLoS Pathog Year: 2020 Document type: Article Affiliation country: Country of publication: